Edition:
United Kingdom

Torrent Pharmaceuticals Ltd (TORP.NS)

TORP.NS on National Stock Exchange of India

1,470.55INR
22 Jun 2018
Change (% chg)

Rs-5.85 (-0.40%)
Prev Close
Rs1,476.40
Open
Rs1,475.55
Day's High
Rs1,476.00
Day's Low
Rs1,445.00
Volume
197,804
Avg. Vol
230,389
52-wk High
Rs1,525.00
52-wk Low
Rs1,147.30

Chart for

About

Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products. The Company operates in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastrointestinal, diabetology, anti-infective, anti-diabetics and pain management segments.... (more)

Overall

Beta: 0.25
Market Cap(Mil.): Rs214,269.80
Shares Outstanding(Mil.): 169.22
Dividend: 4.00
Yield (%): 1.11

Financials

  TORP.NS Industry Sector
P/E (TTM): 25.82 30.95 32.74
EPS (TTM): 49.04 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.08

BRIEF-India's Torrent Pharmaceuticals Gets Shareholders' Nod For Increasing Borrowing Limits

* GETS SHAREHOLDERS' NOD TO RAISE AUTHORSIED SHARE CAPITAL FROM 1.25 BILLION RUPEES TO 1.50 BILLION RUPEES

01 Mar 2018

BRIEF-Torrent Pharmaceuticals Dec-qtr Net Profit Plunges 75 Pct

* DEC QUARTER CONSOL NET PROFIT 580 MILLION RUPEES VERSUS PROFIT OF 2.29 BILLION RUPEES LAST YEAR

08 Feb 2018

French and Benelux stocks-Factors to watch on Feb 6

Feb 6 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

06 Feb 2018

Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs - sources

LONDON/FRANKFURT Brazilian drugs firm EMS and Indian rival Torrent Pharma have emerged as the only industry bidders for Sanofi's generic drugs unit, battling a series of buyout funds for an asset worth as much as $2.4 billion (£1.7 billion), sources familiar with the matter told Reuters.

05 Feb 2018

Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs: sources

LONDON/FRANKFURT Brazilian drugs firm EMS and Indian rival Torrent Pharma have emerged as the only industry bidders for Sanofi's generic drugs unit, battling a series of buyout funds for an asset worth as much as $2.4 billion, sources familiar with the matter told Reuters.

05 Feb 2018

Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs -sources

LONDON/FRANKFURT, Feb 5 Brazilian drugs firm EMS and Indian rival Torrent Pharma have emerged as the only industry bidders for Sanofi's generic drugs unit, battling a series of buyout funds for an asset worth as much as $2.4 billion, sources familiar with the matter told Reuters.

05 Feb 2018

BRIEF-Torrent Pharma Approves Issue Of NCDs Via Private Placement Worth Up To 125 Bln Rupees

* SAYS APPROVED ENHANCEMENT OF BORROWING LIMITS TO 150 BILLION RUPEES

25 Jan 2018

BRIEF-Torrent Pharmaceuticals ‍To Consider Raising Of Funds

* TO CONSIDER RAISING OF FUNDS VIA ISSUE OF SHARES INCLUDING CONVERTIBLE BONDS / DEBENTURES THROUGH QIP OR OTHER MODES​

22 Jan 2018

BRIEF-Torrent Pharmaceuticals Buys Bio-Pharm Inc

* PLANS FURTHER INVESTMENTS TO EXPAND BIO-PHARM FACILITIES; WILL INCREASE NUMBER OF PRODUCT FILINGS FROM BIO-PHARM Source text - http://bit.ly/2rjIxJS Further company coverage:

18 Jan 2018

Earnings vs. Estimates